Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Proteome Research|June 2, 2022
PPI-Affinity: A Web Tool for the Prediction and Optimization of Protein-Peptide and Protein-Protein Binding AffinitySandra Romero-Molina, Yasser B Ruiz-Blanco, Joel Mieres-Perez, et al.
Journal of Medicinal Chemistry|June 16, 2023
Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological ApplicationsRaghuvir Haridas Gaonkar, Yannik Tim Schmidt, Rosalba Mansi, et al.
International Journal of Molecular Sciences|August 10, 2024
An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR-ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic LeukemiaJohanna Pohl, Angela Litz, Omar El Ayoubi, et al.
Cancers|March 6, 2021
Targeting of CXCR4 by the Naturally Occurring CXCR4 Antagonist EPI-X4 in Waldenström's MacroglobulinemiaLisa Marie Kaiser, Mirja Harms, Daniel Sauter, et al.
Medical Microbiology and Immunology|February 9, 2017
Development of a high-throughput colorimetric Zika virus infection assayJanis A Müller, Mirja Harms, Axel Schubert, et al.
International Journal of Molecular Sciences|March 13, 2025
CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell LymphomaNupur Khunti, Manish Kumar, Moumita Datta, et al.
Bioconjugate Chemistry|September 4, 2023
Peptide Bispecifics Inhibiting HIV-1 Infection by an Orthogonal Chemical and Supramolecular StrategyDominik Schauenburg, Fabian Zech, Astrid Johanna Heck, et al.
International Journal of Molecular Sciences|December 11, 2022
Advanced EPI-X4 Derivatives Covalently Bind Human Serum Albumin Resulting in Prolonged Plasma StabilityArmando Rodríguez-Alfonso, Astrid Heck, Yasser Bruno Ruiz-Blanco, et al.
Communications Biology|September 23, 2021
Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonistsPandian Sokkar, Mirja Harms, Christina Stürzel, et al.
Advanced Healthcare Materials|September 26, 2017
Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic VirusesFranziska Schandock, Camilla Frich Riber, Annika Röcker, et al.
Pageof 4